$GILD Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis

on June 12, 2021 News and Tags: , , , with 0 comments
Time:
10:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

on June 10, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Reducing Our Footprint: It’s Time to Get More Ambitious

on June 9, 2021 News and Tags: , , , with 0 comments
Time:
4:50 AM
Symbol:
GILD
Source:
3BL Media: Corporate Social Responsibility, Energy and Health News
Read more

$GILD Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021

on May 19, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences to Present at Upcoming Investor Conferences

on May 14, 2021 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences Announces Second Quarter 2021 Dividend

on April 29, 2021 News and Tags: , , , with 0 comments
Time:
4:02 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India

on April 26, 2021 News and Tags: , , , with 0 comments
Time:
6:34 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer

on April 14, 2021 News and Tags: , , , with 0 comments
Time:
9:25 AM
Symbol:
GILD
Source:
PR Newswire
Read more

$GILD U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer

on April 13, 2021 News and Tags: , , , with 0 comments
Time:
5:42 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metasta

on April 8, 2021 News and Tags: , , , with 0 comments
Time:
8:10 PM
Symbol:
GILD
Source:
PR Newswire
Read more

$ABBV Pharma Companies Seeking to Improve Health Outcomes With Innovative Products

on April 8, 2021 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
8:50 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$GILD FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

on April 7, 2021 News and Tags: , , , with 0 comments
Time:
7:53 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD European Medicines Agency Validates Marketing Authorization Application for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer

on March 25, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead and Novo Nordisk Expand NASH Clinical Collaboration

on March 18, 2021 News and Tags: , , , with 0 comments
Time:
5:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI

on March 6, 2021 News and Tags: , , , with 0 comments
Time:
7:01 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy

on March 5, 2021 News and Tags: , , , with 0 comments
Time:
7:49 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead to Present New Data at CROI 2021 Demonstrating the Company’s Commitment to Addressing Urgent Global Health Needs

on March 2, 2021 News and Tags: , , , with 0 comments
Time:
5:21 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach

on February 16, 2021 News and Tags: , , , with 0 comments
Time:
10:30 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Kite Announces New ZUMA-1 Cohort Analysis Evaluating Prophylactic Corticosteroid Use With Yescarta® in Patients With Relapsed or Refractory Large B-cell lymphoma

on February 10, 2021 News and Tags: , , , with 0 comments
Time:
5:15 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more